Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Supernus Pharmaceuticals Inc Share Price

SUPN

NMQ

$51.35

+$1.15

(2.29%)

Industry: Pharmaceuticals Sector: Health Care

Supernus Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Supernus Pharmaceuticals Inc Share Price Chart

Supernus Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$2.88B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

773.99K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.72

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$29.16 L

$57.65 H

$51.35

About Supernus Pharmaceuticals Inc, Common Stock

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States. The company offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD); GOCOVRI for the treatment of dyskinesia and levodopa/carbidopa in patients with Parkinson's Disease (PD); Oxtellar XR, an extended-release oxcarbazepine product indicated for the monotherapy treatment of partial onset epilepsy seizures; and APOKYN for the acute and intermittent treatment of hypomobility or off episodes in patients with advanced PD. It also provides Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; XADAGO for the treatment of levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and chronic sialorrhea. In addition, the company develops ONAPGO, which received FDA approval, for the treatment of motor fluctuations in adults with advanced PD; SPN-817, a first-in-class selective acetylcholinesterase inhibitor, which is in Phase 2 clinical trial, for the treatment of epilepsy, partial seizures, Dravet syndrome, and Lennox-Gaustaut syndrome; SPN-820, a small molecule in Phase 2 clinical trial for treating resistant depression; SPN-443, a stimulant in Phase 1 trial for the treatment of ADHD/CNS; and SPN-446, a preclinical product for CNS. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development agreement with Navitor Inc. for the conduct of Phase 2 clinical program of SPN-820. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is based in Rockville, Maryland. more

Industry: PharmaceuticalsSector: Health Care

Supernus Pharmaceuticals Inc Stock Returns

Time Frame	SUPN	Sector	S&P500
1-Week Return	3.01%	1.07%	0.74%
1-Month Return	3.07%	1.46%	1.28%
3-Month Return	12.36%	3.51%	3.6%
6-Month Return	22.26%	15.29%	7.31%
1-Year Return	53.19%	7.7%	11.97%
3-Year Return	32.28%	21.02%	72.07%
5-Year Return	73.42%	37.81%	76.01%
10-Year Return	276.47%	139.15%	258.47%

Time Frame	SUPN	Sector	S&P500
1-Week Return	369.43%	74.19%	46.88%
1-Month Return	44.47%	19.29%	16.74%
3-Month Return	60.42%	15.02%	15.42%
6-Month Return	50.31%	33.44%	15.38%
1-Year Return	53.19%	7.70%	11.97%
3-Year Return	9.77%	6.57%	19.83%
5-Year Return	11.64%	6.62%	11.97%
10-Year Return	14.18%	9.11%	13.62%

Supernus Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	520.40M	579.77M	667.24M	607.52M	661.82M	[{"date":"2020-12-31","value":77.99,"profit":true},{"date":"2021-12-31","value":86.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.05,"profit":true},{"date":"2024-12-31","value":99.19,"profit":true}]
Cost of Revenue	52.46M	75.06M	87.22M	83.78M	77.91M	[{"date":"2020-12-31","value":60.14,"profit":true},{"date":"2021-12-31","value":86.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.05,"profit":true},{"date":"2024-12-31","value":89.32,"profit":true}]
Gross Profit	467.94M	504.71M	580.02M	523.74M	583.91M	[{"date":"2020-12-31","value":80.14,"profit":true},{"date":"2021-12-31","value":86.44,"profit":true},{"date":"2022-12-31","value":99.33,"profit":true},{"date":"2023-12-31","value":89.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	89.92%	87.05%	86.93%	86.21%	88.23%	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":96.81,"profit":true},{"date":"2022-12-31","value":96.67,"profit":true},{"date":"2023-12-31","value":95.87,"profit":true},{"date":"2024-12-31","value":98.12,"profit":true}]

Operating Expenses	294.24M	418.69M	533.89M	529.01M	502.25M	[{"date":"2020-12-31","value":55.11,"profit":true},{"date":"2021-12-31","value":78.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.09,"profit":true},{"date":"2024-12-31","value":94.07,"profit":true}]
Operating Income	173.70M	86.03M	46.12M	(5.27M)	81.67M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":49.53,"profit":true},{"date":"2022-12-31","value":26.55,"profit":true},{"date":"2023-12-31","value":-3.03,"profit":false},{"date":"2024-12-31","value":47.02,"profit":true}]
Total Non-Operating Income/Expense	(10.10M)	(25.71M)	29.24M	14.90M	32.41M	[{"date":"2020-12-31","value":-31.17,"profit":false},{"date":"2021-12-31","value":-79.33,"profit":false},{"date":"2022-12-31","value":90.22,"profit":true},{"date":"2023-12-31","value":45.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	168.65M	73.17M	60.74M	2.77M	97.87M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":43.39,"profit":true},{"date":"2022-12-31","value":36.02,"profit":true},{"date":"2023-12-31","value":1.64,"profit":true},{"date":"2024-12-31","value":58.03,"profit":true}]
Income Taxes	41.70M	19.75M	32.00K	1.45M	24.00M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":47.37,"profit":true},{"date":"2022-12-31","value":0.08,"profit":true},{"date":"2023-12-31","value":3.48,"profit":true},{"date":"2024-12-31","value":57.57,"profit":true}]
Income After Taxes	126.95M	53.42M	60.71M	1.32M	73.86M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":42.08,"profit":true},{"date":"2022-12-31","value":47.82,"profit":true},{"date":"2023-12-31","value":1.04,"profit":true},{"date":"2024-12-31","value":58.18,"profit":true}]

Income From Continuous Operations	126.95M	53.42M	60.71M	25.62M	73.86M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":42.08,"profit":true},{"date":"2022-12-31","value":47.82,"profit":true},{"date":"2023-12-31","value":20.18,"profit":true},{"date":"2024-12-31","value":58.18,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	126.95M	53.42M	60.71M	1.32M	73.86M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":42.08,"profit":true},{"date":"2022-12-31","value":47.82,"profit":true},{"date":"2023-12-31","value":1.04,"profit":true},{"date":"2024-12-31","value":58.18,"profit":true}]

EPS (Diluted)	2.36	0.98	1.03	1.40	1.86	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.53,"profit":true},{"date":"2022-12-31","value":43.64,"profit":true},{"date":"2023-12-31","value":59.32,"profit":true},{"date":"2024-12-31","value":78.74,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	11.41%	15.09%	(8.95%)	8.94%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":75.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-59.33,"profit":false},{"date":"2024-12-31","value":59.24,"profit":true}]
Cost of Revenue	-	43.09%	16.20%	(3.95%)	(7.01%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":37.6,"profit":true},{"date":"2023-12-31","value":-9.16,"profit":false},{"date":"2024-12-31","value":-16.27,"profit":false}]
Gross Profit	-	7.86%	14.92%	(9.70%)	11.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":52.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-65.03,"profit":false},{"date":"2024-12-31","value":77,"profit":true}]
Gross Margin	-	(3.19%)	(0.14%)	(0.83%)	2.34%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-136.11,"profit":false},{"date":"2022-12-31","value":-6.15,"profit":false},{"date":"2023-12-31","value":-35.29,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	-	42.29%	27.52%	(0.91%)	(5.06%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":65.06,"profit":true},{"date":"2023-12-31","value":-2.16,"profit":false},{"date":"2024-12-31","value":-11.96,"profit":false}]
Operating Income	-	(50.47%)	(46.39%)	(111.42%)	(1649.93%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	154.53%	(213.73%)	(49.05%)	117.56%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-138.31,"profit":false},{"date":"2023-12-31","value":-31.74,"profit":false},{"date":"2024-12-31","value":76.07,"profit":true}]
Pre-Tax Income	-	(56.61%)	(16.99%)	(95.44%)	3434.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.65,"profit":false},{"date":"2022-12-31","value":-0.49,"profit":false},{"date":"2023-12-31","value":-2.78,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	(52.63%)	(99.84%)	4440.63%	1552.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.19,"profit":false},{"date":"2022-12-31","value":-2.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":34.95,"profit":true}]
Income After Taxes	-	(57.92%)	13.64%	(97.83%)	5512.84%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.05,"profit":false},{"date":"2022-12-31","value":0.25,"profit":true},{"date":"2023-12-31","value":-1.77,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	(57.92%)	13.64%	(57.80%)	188.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-30.76,"profit":false},{"date":"2022-12-31","value":7.24,"profit":true},{"date":"2023-12-31","value":-30.7,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(57.92%)	13.64%	(97.83%)	5512.84%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.05,"profit":false},{"date":"2022-12-31","value":0.25,"profit":true},{"date":"2023-12-31","value":-1.77,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(58.47%)	5.10%	35.92%	32.74%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-162.78,"profit":false},{"date":"2022-12-31","value":14.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.13,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	175.69M	174.16M	149.82M	165.45M	192.10M	[{"date":"2024-09-30","value":91.46,"profit":true},{"date":"2024-12-31","value":90.66,"profit":true},{"date":"2025-03-31","value":77.99,"profit":true},{"date":"2025-06-30","value":86.13,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	17.58M	26.10M	15.76M	16.83M	48.33M	[{"date":"2024-09-30","value":36.38,"profit":true},{"date":"2024-12-31","value":54,"profit":true},{"date":"2025-03-31","value":32.61,"profit":true},{"date":"2025-06-30","value":34.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	158.11M	148.06M	134.06M	148.63M	143.77M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":93.65,"profit":true},{"date":"2025-03-31","value":84.79,"profit":true},{"date":"2025-06-30","value":94,"profit":true},{"date":"2025-09-30","value":90.93,"profit":true}]
Gross Margin	89.99%	85.01%	89.48%	89.83%	74.84%	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":94.47,"profit":true},{"date":"2025-03-31","value":99.43,"profit":true},{"date":"2025-06-30","value":99.82,"profit":true},{"date":"2025-09-30","value":83.16,"profit":true}]

Operating Expenses	117.26M	126.66M	144.32M	136.49M	204.00M	[{"date":"2024-09-30","value":57.48,"profit":true},{"date":"2024-12-31","value":62.09,"profit":true},{"date":"2025-03-31","value":70.74,"profit":true},{"date":"2025-06-30","value":66.9,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	40.84M	21.41M	(10.26M)	12.14M	(60.23M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":52.41,"profit":true},{"date":"2025-03-31","value":-25.11,"profit":false},{"date":"2025-06-30","value":29.72,"profit":true},{"date":"2025-09-30","value":-147.46,"profit":false}]
Total Non-Operating Income/Expense	8.20M	9.95M	8.85M	9.06M	4.55M	[{"date":"2024-09-30","value":82.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":88.91,"profit":true},{"date":"2025-06-30","value":90.98,"profit":true},{"date":"2025-09-30","value":45.75,"profit":true}]
Pre-Tax Income	44.94M	26.38M	(5.83M)	16.67M	(57.95M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":58.7,"profit":true},{"date":"2025-03-31","value":-12.97,"profit":false},{"date":"2025-06-30","value":37.09,"profit":true},{"date":"2025-09-30","value":-128.95,"profit":false}]
Income Taxes	6.45M	11.05M	6.00M	(5.83M)	(12.84M)	[{"date":"2024-09-30","value":58.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":54.24,"profit":true},{"date":"2025-06-30","value":-52.74,"profit":false},{"date":"2025-09-30","value":-116.13,"profit":false}]
Income After Taxes	38.50M	15.33M	(11.83M)	22.50M	(45.12M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":39.82,"profit":true},{"date":"2025-03-31","value":-30.72,"profit":false},{"date":"2025-06-30","value":58.44,"profit":true},{"date":"2025-09-30","value":-117.2,"profit":false}]

Income From Continuous Operations	38.50M	15.33M	(11.83M)	22.50M	(45.12M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":39.82,"profit":true},{"date":"2025-03-31","value":-30.72,"profit":false},{"date":"2025-06-30","value":58.44,"profit":true},{"date":"2025-09-30","value":-117.2,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	38.50M	15.33M	(11.83M)	22.50M	(45.12M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":39.82,"profit":true},{"date":"2025-03-31","value":-30.72,"profit":false},{"date":"2025-06-30","value":58.44,"profit":true},{"date":"2025-09-30","value":-117.2,"profit":false}]

EPS (Diluted)	0.69	0.55	0.44	0.40	(0.80)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":79.46,"profit":true},{"date":"2025-03-31","value":63.23,"profit":true},{"date":"2025-06-30","value":57.97,"profit":true},{"date":"2025-09-30","value":-115.94,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(0.87%)	(13.97%)	10.43%	16.11%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-5.41,"profit":false},{"date":"2025-03-31","value":-86.75,"profit":false},{"date":"2025-06-30","value":64.76,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	-	48.43%	(39.60%)	6.75%	187.22%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":25.87,"profit":true},{"date":"2025-03-31","value":-21.15,"profit":false},{"date":"2025-06-30","value":3.61,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	(6.35%)	(9.46%)	10.86%	(3.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-58.48,"profit":false},{"date":"2025-03-31","value":-87.03,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-30.06,"profit":false}]
Gross Margin	-	(5.53%)	5.25%	0.39%	(16.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-105.33,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":7.47,"profit":true},{"date":"2025-09-30","value":-317.76,"profit":false}]

Operating Expenses	-	8.01%	13.94%	(5.43%)	49.47%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":16.2,"profit":true},{"date":"2025-03-31","value":28.19,"profit":true},{"date":"2025-06-30","value":-10.97,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	-	(47.59%)	(147.91%)	(218.38%)	(596.10%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	21.45%	(11.09%)	2.33%	(49.71%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-51.71,"profit":false},{"date":"2025-06-30","value":10.85,"profit":true},{"date":"2025-09-30","value":-231.77,"profit":false}]
Pre-Tax Income	-	(41.30%)	(122.10%)	(385.87%)	(447.68%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income Taxes	-	71.49%	(45.76%)	(197.23%)	120.19%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":59.48,"profit":true},{"date":"2025-03-31","value":-38.07,"profit":false},{"date":"2025-06-30","value":-164.1,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income After Taxes	-	(60.18%)	(177.16%)	(290.23%)	(300.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Income From Continuous Operations	-	(60.18%)	(177.16%)	(290.23%)	(300.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(60.18%)	(177.16%)	(290.23%)	(300.53%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

EPS (Diluted)	-	(20.54%)	(20.43%)	(8.32%)	(300.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	630.42M	601.59M	734.15M	493.11M	686.07M	[{"date":"2020-12-31","value":85.87,"profit":true},{"date":"2021-12-31","value":81.94,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.17,"profit":true},{"date":"2024-12-31","value":93.45,"profit":true}]
Non-current Assets	873.68M	1.09B	968.36M	784.56M	682.00M	[{"date":"2020-12-31","value":80.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.04,"profit":true},{"date":"2023-12-31","value":72.14,"profit":true},{"date":"2024-12-31","value":62.71,"profit":true}]
Total Assets	1.50B	1.69B	1.70B	1.28B	1.37B	[{"date":"2020-12-31","value":88.35,"profit":true},{"date":"2021-12-31","value":99.22,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.05,"profit":true},{"date":"2024-12-31","value":80.36,"profit":true}]

Total Liabilities
Current Liabilities	245.11M	315.38M	687.96M	290.20M	292.40M	[{"date":"2020-12-31","value":35.63,"profit":true},{"date":"2021-12-31","value":45.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.18,"profit":true},{"date":"2024-12-31","value":42.5,"profit":true}]
Non-current Liabilities	514.14M	557.92M	128.35M	65.96M	39.94M	[{"date":"2020-12-31","value":92.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23,"profit":true},{"date":"2023-12-31","value":11.82,"profit":true},{"date":"2024-12-31","value":7.16,"profit":true}]
Total Liabilities	759.24M	873.30M	816.30M	356.16M	332.34M	[{"date":"2020-12-31","value":86.94,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.47,"profit":true},{"date":"2023-12-31","value":40.78,"profit":true},{"date":"2024-12-31","value":38.06,"profit":true}]

Total Shareholders' equity
Common Stock	53.00K	53.00K	54.00K	55.00K	56.00K	[{"date":"2020-12-31","value":94.64,"profit":true},{"date":"2021-12-31","value":94.64,"profit":true},{"date":"2022-12-31","value":96.43,"profit":true},{"date":"2023-12-31","value":98.21,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	326.50M	379.92M	481.25M	482.56M	556.43M	[{"date":"2020-12-31","value":58.68,"profit":true},{"date":"2021-12-31","value":68.28,"profit":true},{"date":"2022-12-31","value":86.49,"profit":true},{"date":"2023-12-31","value":86.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	409.33M	434.34M	408.12M	439.49M	479.44M	[{"date":"2020-12-31","value":85.38,"profit":true},{"date":"2021-12-31","value":90.59,"profit":true},{"date":"2022-12-31","value":85.12,"profit":true},{"date":"2023-12-31","value":91.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	744.86M	815.85M	886.20M	921.52M	1.04B	[{"date":"2020-12-31","value":71.92,"profit":true},{"date":"2021-12-31","value":78.77,"profit":true},{"date":"2022-12-31","value":85.56,"profit":true},{"date":"2023-12-31","value":88.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	1.50B	1.69B	1.70B	1.28B	1.37B	[{"date":"2020-12-31","value":88.35,"profit":true},{"date":"2021-12-31","value":99.22,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.05,"profit":true},{"date":"2024-12-31","value":80.36,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(4.57%)	22.04%	(32.83%)	39.13%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11.69,"profit":false},{"date":"2022-12-31","value":56.31,"profit":true},{"date":"2023-12-31","value":-83.9,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	24.48%	(10.96%)	(18.98%)	(13.07%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-44.77,"profit":false},{"date":"2023-12-31","value":-77.53,"profit":false},{"date":"2024-12-31","value":-53.4,"profit":false}]
Total Assets	-	12.30%	0.79%	(24.95%)	7.08%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":6.43,"profit":true},{"date":"2023-12-31","value":-202.82,"profit":false},{"date":"2024-12-31","value":57.51,"profit":true}]

Total Liabilities
Current Liabilities	-	28.67%	118.14%	(57.82%)	0.76%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":24.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-48.94,"profit":false},{"date":"2024-12-31","value":0.64,"profit":true}]
Non-current Liabilities	-	8.52%	(77.00%)	(48.61%)	(39.44%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-904.09,"profit":false},{"date":"2023-12-31","value":-570.74,"profit":false},{"date":"2024-12-31","value":-463.16,"profit":false}]
Total Liabilities	-	15.02%	(6.53%)	(56.37%)	(6.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-43.45,"profit":false},{"date":"2023-12-31","value":-375.24,"profit":false},{"date":"2024-12-31","value":-44.51,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	1.89%	1.85%	1.82%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.15,"profit":true},{"date":"2024-12-31","value":96.36,"profit":true}]
Retained Earnings	-	16.36%	26.67%	0.27%	15.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":61.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.03,"profit":true},{"date":"2024-12-31","value":57.39,"profit":true}]
Other Stockholders' Equity	-	6.11%	(6.04%)	7.69%	9.09%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":67.21,"profit":true},{"date":"2022-12-31","value":-66.42,"profit":false},{"date":"2023-12-31","value":84.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	9.53%	8.62%	3.98%	12.39%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":76.9,"profit":true},{"date":"2022-12-31","value":69.57,"profit":true},{"date":"2023-12-31","value":32.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	12.30%	0.79%	(24.95%)	7.08%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":6.43,"profit":true},{"date":"2023-12-31","value":-202.82,"profit":false},{"date":"2024-12-31","value":57.51,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	640.00M	686.07M	687.58M	738.87M	593.89M	[{"date":"2024-09-30","value":86.62,"profit":true},{"date":"2024-12-31","value":92.85,"profit":true},{"date":"2025-03-31","value":93.06,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":80.38,"profit":true}]
Non-current Assets	702.70M	682.00M	659.71M	643.54M	825.86M	[{"date":"2024-09-30","value":85.09,"profit":true},{"date":"2024-12-31","value":82.58,"profit":true},{"date":"2025-03-31","value":79.88,"profit":true},{"date":"2025-06-30","value":77.92,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	1.34B	1.37B	1.35B	1.38B	1.42B	[{"date":"2024-09-30","value":94.57,"profit":true},{"date":"2024-12-31","value":96.36,"profit":true},{"date":"2025-03-31","value":94.9,"profit":true},{"date":"2025-06-30","value":97.37,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	291.51M	292.40M	281.77M	286.36M	330.63M	[{"date":"2024-09-30","value":88.17,"profit":true},{"date":"2024-12-31","value":88.44,"profit":true},{"date":"2025-03-31","value":85.22,"profit":true},{"date":"2025-06-30","value":86.61,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	44.04M	39.94M	34.81M	32.15M	39.46M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90.69,"profit":true},{"date":"2025-03-31","value":79.04,"profit":true},{"date":"2025-06-30","value":72.99,"profit":true},{"date":"2025-09-30","value":89.59,"profit":true}]
Total Liabilities	335.55M	332.34M	316.58M	318.50M	370.09M	[{"date":"2024-09-30","value":90.67,"profit":true},{"date":"2024-12-31","value":89.8,"profit":true},{"date":"2025-03-31","value":85.54,"profit":true},{"date":"2025-06-30","value":86.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	55.00K	56.00K	56.00K	56.00K	57.00K	[{"date":"2024-09-30","value":96.49,"profit":true},{"date":"2024-12-31","value":98.25,"profit":true},{"date":"2025-03-31","value":98.25,"profit":true},{"date":"2025-06-30","value":98.25,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	541.10M	556.43M	544.60M	567.10M	521.98M	[{"date":"2024-09-30","value":95.42,"profit":true},{"date":"2024-12-31","value":98.12,"profit":true},{"date":"2025-03-31","value":96.03,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.04,"profit":true}]
Other Stockholders' Equity	465.92M	479.44M	486.21M	496.95M	527.70M	[{"date":"2024-09-30","value":88.29,"profit":true},{"date":"2024-12-31","value":90.85,"profit":true},{"date":"2025-03-31","value":92.14,"profit":true},{"date":"2025-06-30","value":94.17,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	1.01B	1.04B	1.03B	1.06B	1.05B	[{"date":"2024-09-30","value":94.67,"profit":true},{"date":"2024-12-31","value":97.35,"profit":true},{"date":"2025-03-31","value":96.88,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":98.66,"profit":true}]

Total Liabilities & Shareholders Equity	1.34B	1.37B	1.35B	1.38B	1.42B	[{"date":"2024-09-30","value":94.57,"profit":true},{"date":"2024-12-31","value":96.36,"profit":true},{"date":"2025-03-31","value":94.9,"profit":true},{"date":"2025-06-30","value":97.37,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	7.20%	0.22%	7.46%	(19.62%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":96.51,"profit":true},{"date":"2025-03-31","value":2.96,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-263.08,"profit":false}]
Non-current Assets	-	(2.95%)	(3.27%)	(2.45%)	28.33%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10.4,"profit":false},{"date":"2025-03-31","value":-11.54,"profit":false},{"date":"2025-06-30","value":-8.65,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	1.89%	(1.52%)	2.61%	2.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":69.94,"profit":true},{"date":"2025-03-31","value":-56.23,"profit":false},{"date":"2025-06-30","value":96.47,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	0.30%	(3.63%)	1.63%	15.46%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.97,"profit":true},{"date":"2025-03-31","value":-23.51,"profit":false},{"date":"2025-06-30","value":10.53,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	-	(9.31%)	(12.84%)	(7.66%)	22.75%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-40.92,"profit":false},{"date":"2025-03-31","value":-56.45,"profit":false},{"date":"2025-06-30","value":-33.69,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	(0.96%)	(4.74%)	0.61%	16.20%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-5.91,"profit":false},{"date":"2025-03-31","value":-29.27,"profit":false},{"date":"2025-06-30","value":3.74,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	1.82%	-	-	1.79%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":98.21,"profit":true}]
Retained Earnings	-	2.83%	(2.13%)	4.13%	(7.96%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.57,"profit":true},{"date":"2025-03-31","value":-51.45,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-192.57,"profit":false}]
Other Stockholders' Equity	-	2.90%	1.41%	2.21%	6.19%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":46.89,"profit":true},{"date":"2025-03-31","value":22.81,"profit":true},{"date":"2025-06-30","value":35.68,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	2.84%	(0.49%)	3.22%	(1.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":88.12,"profit":true},{"date":"2025-03-31","value":-15.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-41.54,"profit":false}]

Total Liabilities & Shareholders Equity	-	1.89%	(1.52%)	2.61%	2.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":69.94,"profit":true},{"date":"2025-03-31","value":-56.23,"profit":false},{"date":"2025-06-30","value":96.47,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	138.40M	127.13M	116.83M	111.08M	171.95M	[{"date":"2020-12-31","value":80.49,"profit":true},{"date":"2021-12-31","value":73.93,"profit":true},{"date":"2022-12-31","value":67.94,"profit":true},{"date":"2023-12-31","value":64.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(34.70M)	(81.91M)	(216.66M)	268.73M	(189.87M)	[{"date":"2020-12-31","value":-12.91,"profit":false},{"date":"2021-12-31","value":-30.48,"profit":false},{"date":"2022-12-31","value":-80.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-70.65,"profit":false}]

Financing Activities
Net Financing Cash Flow	3.56M	(130.42M)	(10.48M)	(397.88M)	12.19M	[{"date":"2020-12-31","value":29.19,"profit":true},{"date":"2021-12-31","value":-1069.63,"profit":false},{"date":"2022-12-31","value":-85.93,"profit":false},{"date":"2023-12-31","value":-3263.18,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	107.26M	(85.21M)	(110.31M)	(18.07M)	(5.72M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-79.44,"profit":false},{"date":"2022-12-31","value":-102.85,"profit":false},{"date":"2023-12-31","value":-16.84,"profit":false},{"date":"2024-12-31","value":-5.34,"profit":false}]

Free Cash Flow
Free Cash Flow	134.95M	125.08M	116.41M	110.53M	171.23M	[{"date":"2020-12-31","value":78.81,"profit":true},{"date":"2021-12-31","value":73.05,"profit":true},{"date":"2022-12-31","value":67.99,"profit":true},{"date":"2023-12-31","value":64.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(8.14%)	(8.10%)	(4.91%)	54.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.86,"profit":false},{"date":"2022-12-31","value":-14.79,"profit":false},{"date":"2023-12-31","value":-8.97,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	136.07%	164.50%	(224.03%)	(170.65%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":82.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-136.19,"profit":false},{"date":"2024-12-31","value":-103.74,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(3764.51%)	(91.97%)	3697.65%	(103.06%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-101.81,"profit":false},{"date":"2022-12-31","value":-2.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-2.79,"profit":false}]

Net Change in Cash	-	(179.44%)	29.47%	(83.62%)	(68.32%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-608.94,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-283.78,"profit":false},{"date":"2024-12-31","value":-231.86,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(7.31%)	(6.93%)	(5.05%)	54.91%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-13.32,"profit":false},{"date":"2022-12-31","value":-12.62,"profit":false},{"date":"2023-12-31","value":-9.2,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	53.52M	44.41M	30.60M	58.53M	(61.66M)	[{"date":"2024-09-30","value":91.43,"profit":true},{"date":"2024-12-31","value":75.86,"profit":true},{"date":"2025-03-31","value":52.27,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-105.35,"profit":false}]

Investing Activities
Net Investing Cash Flow	(77.01M)	(12.64M)	37.32M	(30.61M)	48.71M	[{"date":"2024-09-30","value":-158.11,"profit":false},{"date":"2024-12-31","value":-25.95,"profit":false},{"date":"2025-03-31","value":76.62,"profit":true},{"date":"2025-06-30","value":-62.84,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	3.08M	5.89M	(21.40M)	935.00K	21.07M	[{"date":"2024-09-30","value":14.6,"profit":true},{"date":"2024-12-31","value":27.96,"profit":true},{"date":"2025-03-31","value":-101.57,"profit":false},{"date":"2025-06-30","value":4.44,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	(20.42M)	37.66M	46.52M	28.86M	8.11M	[{"date":"2024-09-30","value":-43.89,"profit":false},{"date":"2024-12-31","value":80.96,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":62.05,"profit":true},{"date":"2025-09-30","value":17.43,"profit":true}]

Free Cash Flow
Free Cash Flow	53.32M	44.19M	30.27M	58.08M	(61.79M)	[{"date":"2024-09-30","value":91.8,"profit":true},{"date":"2024-12-31","value":76.09,"profit":true},{"date":"2025-03-31","value":52.12,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-106.39,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(17.03%)	(31.09%)	91.30%	(205.35%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-18.65,"profit":false},{"date":"2025-03-31","value":-34.06,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-224.92,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(83.59%)	(395.28%)	(182.02%)	(259.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	91.54%	(463.31%)	(104.37%)	2153.26%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.25,"profit":true},{"date":"2025-03-31","value":-21.52,"profit":false},{"date":"2025-06-30","value":-4.85,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(284.45%)	23.52%	(37.95%)	(71.90%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1209.16,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-161.33,"profit":false},{"date":"2025-09-30","value":-305.64,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(17.12%)	(31.50%)	91.86%	(206.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-18.63,"profit":false},{"date":"2025-03-31","value":-34.29,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-224.68,"profit":false}]

Supernus Pharmaceuticals Inc Ratios

Supernus Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	SUPN
Cash Ratio	0.85
Current Ratio	1.80
Quick Ratio	1.56

Supernus Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	SUPN
ROA (LTM)	1.52%
ROE (LTM)	-1.86%

Supernus Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	SUPN
Debt Ratio Lower is generally better. Negative is bad.	0.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.74

Supernus Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	SUPN
Trailing PE	NM
Forward PE	20.16
P/S (TTM)	4.22
P/B	2.82
Price/FCF	NM
EV/R	4.00
EV/Ebitda	34.58
PEG	1.47

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Supernus Pharmaceuticals Inc share price today?

Supernus Pharmaceuticals Inc (SUPN) share price today is $51.35

Can Indians buy Supernus Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Supernus Pharmaceuticals Inc (SUPN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SUPN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Supernus Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Supernus Pharmaceuticals Inc (SUPN) via the Vested app. You can start investing in Supernus Pharmaceuticals Inc (SUPN) with a minimum investment of $1.

How to invest in Supernus Pharmaceuticals Inc shares from India?

You can invest in shares of Supernus Pharmaceuticals Inc (SUPN) via Vested in three simple steps:

Click on Sign Up or Invest in SUPN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Supernus Pharmaceuticals Inc shares

What is Supernus Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Supernus Pharmaceuticals Inc (SUPN) is $57.65. The 52-week low price of Supernus Pharmaceuticals Inc (SUPN) is $29.16.

What is Supernus Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Supernus Pharmaceuticals Inc (SUPN) is

What is Supernus Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Supernus Pharmaceuticals Inc (SUPN) is 2.82

What is Supernus Pharmaceuticals Inc dividend yield?

The dividend yield of Supernus Pharmaceuticals Inc (SUPN) is 0.00%

What is the Market Cap of Supernus Pharmaceuticals Inc?

The market capitalization of Supernus Pharmaceuticals Inc (SUPN) is $2.88B

What is Supernus Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Supernus Pharmaceuticals Inc is SUPN

How Can Investors Use Supernus Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Supernus Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Supernus Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Supernus Pharmaceuticals Inc shares for Indian investors?

When investing in Supernus Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Supernus Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Supernus Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Supernus Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Supernus Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Supernus Pharmaceuticals Inc Share Price

Supernus Pharmaceuticals Inc Analyst Forecast

Supernus Pharmaceuticals Inc Share Price Chart

Supernus Pharmaceuticals Inc Key Stock Metrics

About Supernus Pharmaceuticals Inc, Common Stock

Supernus Pharmaceuticals Inc Stock Returns

Supernus Pharmaceuticals Inc Financials

Supernus Pharmaceuticals Inc Ratios

Supernus Pharmaceuticals Inc Liquidity Ratios

Supernus Pharmaceuticals Inc Asset Efficiency Ratios

Supernus Pharmaceuticals Inc Liability Ratios

Supernus Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Supernus Pharmaceuticals Inc Share Price

Supernus Pharmaceuticals Inc Analyst Forecast

Supernus Pharmaceuticals Inc Share Price Chart

Supernus Pharmaceuticals Inc Key Stock Metrics

About Supernus Pharmaceuticals Inc, Common Stock

Supernus Pharmaceuticals Inc Stock Returns

Supernus Pharmaceuticals Inc Financials

Supernus Pharmaceuticals Inc Ratios

Supernus Pharmaceuticals Inc Liquidity Ratios

Supernus Pharmaceuticals Inc Asset Efficiency Ratios

Supernus Pharmaceuticals Inc Liability Ratios

Supernus Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²